2024 ASCO® Annual Meeting Insights Hub
Meeting coverage & Vumedi’s exclusive highlights, all in one place.
ASCO® 2024 Insights: "ETOP 13-18 BEAT-meso Trial - Bevacizumab + Chemo +/- Atezolizumab as 1L Treatment for Advanced Pleural Mesothelioma"
By
2024 ASCO® Annual Meeting Insights Hub
FEATURING
Sanjay Popat
By
2024 ASCO® Annual Meeting Insights Hub
FEATURING
Sanjay Popat
Comments 0
Login to view comments.
Click here to Login
